Black Titan Corp (NASDAQ:BTTC) Short Interest Update

Black Titan Corp (NASDAQ:BTTC) was the recipient of a large drop in short interest in the month of September. As of September 15th, there was short interest totaling 10,495 shares, a drop of 51.6% from the August 31st total of 21,671 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 108,286 shares, the short-interest ratio is currently 0.1 days.

Black Titan Stock Up 1.7%

Shares of Black Titan stock traded up $0.01 on Tuesday, hitting $0.44. The company had a trading volume of 319,703 shares, compared to its average volume of 3,491,045. The stock has a 50-day moving average of $0.59 and a 200-day moving average of $0.94. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.62 and a quick ratio of 4.62. Black Titan has a twelve month low of $0.34 and a twelve month high of $39.00. The firm has a market capitalization of $4.75 million, a P/E ratio of -0.15 and a beta of 1.17.

Black Titan Company Profile

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.